VWO vs XBI
Vanguard FTSE Emerging Markets ETF vs SPDR S&P Biotech ETF
- • VWO has the lower expense ratio at 0.06% vs 0.35% for XBI.
- • VWO pays a higher dividend yield (2.32%).
Side-by-side metrics
| Metric | VWO | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.32% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $163.32B | $10.73B |
YTD return | 10.19% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.78 | 1.10 |
P/E ratio | 16.85 | — |
Last price | $59.67 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VWO top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 14.66% |
| 0700.HK | Tencent Holdings Ltd | 2.74% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 2.26% |
| 2454.TW | MediaTek Inc | 1.62% |
| 2308.TW | Delta Electronics Inc | 1.20% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 0.91% |
| RELIANCE.NS | Reliance Industries Ltd | 0.77% |
| 00939 | China Construction Bank Corp Class H | 0.77% |
| HDFCBANK.NS | HDFC Bank Ltd | 0.72% |
| ICICIBANK.NS | ICICI Bank Ltd | 0.57% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VWO
VWO (Vanguard FTSE Emerging Markets ETF) is Stocks in emerging-market economies. Managed by Vanguard, the fund carries $163.3B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.32%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 14.7% of the portfolio. Real Estate is the fund's largest sector exposure at 2.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.